102 related articles for article (PubMed ID: 18224683)
21. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
[TBL] [Abstract][Full Text] [Related]
22. CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma.
Hömberg N; Adam C; Riedel T; Brenner C; Flatley A; Röcken M; Mocikat R
Int J Cancer; 2014 Dec; 135(12):2825-33. PubMed ID: 24771135
[TBL] [Abstract][Full Text] [Related]
23. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo.
Serre K; Giraudo L; Siret C; Leserman L; Machy P
Eur J Immunol; 2006 Jun; 36(6):1386-97. PubMed ID: 16673447
[TBL] [Abstract][Full Text] [Related]
24. CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy.
Frangione V; Mortara L; Castellani P; De Lerma Barbaro A; Accolla RS
Int J Cancer; 2010 Oct; 127(7):1614-24. PubMed ID: 20091859
[TBL] [Abstract][Full Text] [Related]
25. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
[TBL] [Abstract][Full Text] [Related]
26. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
[TBL] [Abstract][Full Text] [Related]
27. Aged mice develop protective antitumor immune responses with appropriate costimulation.
Lustgarten J; Dominguez AL; Thoman M
J Immunol; 2004 Oct; 173(7):4510-5. PubMed ID: 15383582
[TBL] [Abstract][Full Text] [Related]
28. Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan.
Mortara L; Balza E; Sassi F; Castellani P; Carnemolla B; De Lerma Barbaro A; Fossati S; Tosi G; Accolla RS; Borsi L
Eur J Immunol; 2007 Dec; 37(12):3381-92. PubMed ID: 18022863
[TBL] [Abstract][Full Text] [Related]
29. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ
Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530
[TBL] [Abstract][Full Text] [Related]
30. Naive tumour-specific CD4+ T cells were efficiently primed in acute lymphoblastic leukaemia.
Noyan F; Lieke T; Taubert R; Sievers M; Dywicki J; Hapke M; Falk CS; Manns MP; Jaeckel E; Hardtke-Wolenski M
Scand J Immunol; 2014 Sep; 80(3):161-8. PubMed ID: 24910003
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
32. Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization.
Bour H; Horvath C; Lurquin C; Cerottini JC; MacDonald HR
J Immunol; 1998 Jun; 160(11):5522-9. PubMed ID: 9605156
[TBL] [Abstract][Full Text] [Related]
33. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
[TBL] [Abstract][Full Text] [Related]
34. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
35. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
[TBL] [Abstract][Full Text] [Related]
36. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
[TBL] [Abstract][Full Text] [Related]
37. Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejection.
Moeller M; Haynes NM; Kershaw MH; Jackson JT; Teng MW; Street SE; Cerutti L; Jane SM; Trapani JA; Smyth MJ; Darcy PK
Blood; 2005 Nov; 106(9):2995-3003. PubMed ID: 16030195
[TBL] [Abstract][Full Text] [Related]
38. Targeting high-grade B cell lymphoma with CD19-specific T cells.
Lehmann FM; Maurberger A; Feicht S; Helm F; Ladinig C; Kieback E; Uckert W; Kammertöns T; Kremmer E; Mautner J; Gerbitz A; Bornkamm GW
Int J Cancer; 2014 Sep; 135(5):1153-64. PubMed ID: 24500882
[TBL] [Abstract][Full Text] [Related]
39. Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors.
Lauritzsen GF; Weiss S; Dembic Z; Bogen B
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5700-4. PubMed ID: 7911244
[TBL] [Abstract][Full Text] [Related]
40. Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8+ T cells.
Tascon RE; Ragno S; Lowrie DB; Colston MJ
Immunology; 2000 Jan; 99(1):1-7. PubMed ID: 10651934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
